1.
Prebet T, Bertoli S, Delaunay J, Pigneux A, Delabesse E, Mozziconacci MJ, Bidet A, Recher C, Vey N. Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia. Haematologica [Internet]. 2014Sep.30 [cited 2026Nov.16];99(10):e185-e187. Available from: https://haematologica.org/article/view/7179